Email Discussions
Email discussion disclaimer
Please note that all information and policies are only current at the time the response is sent and individual hospitals should be contacted to ascertain current policies and practices. The responses received are only representative of the hospitals participating in the discussion at the time and do not necessarily indicate a complete picture of current practices.
Information sharing occurs on the understanding that due acknowledgement will be given to the original source and that the information will not be quoted or used out of the context of the discussion. Permission should be sought from the original source before any policy, protocol or guideline is used or applied in another setting.
2017
July
- Aprotinin use in NSW Hospitals
PDF ~ 232 KB - Sodium oxybate for narcolepsy
PDF ~ 234 KB - Management strategies for fentanyl injection shortage
PDF ~ 276 KB
Risk mitigation strategies for hydromorphone storage
PDF ~ 491 KB
May
- Removal of HYDROmorphone 50mg/5mL and upcoming availability of HYDROmorphone 50mg/mL
PDF ~ 264 KB
April
- Safe handling of idarucizumab
PDF ~ 166 KB - Intrathecal fentanyl
PDF ~ 286 KB - Documentation of nitrous oxide administration
PDF ~ 272 KB - TPN Guidance
PDF ~ 177 KB
March
- Perioperative management plan for patients taking regular anticoagulant or antiplatelet agents
PDF ~ 201 KB
January
- Off-label use of rituximab in membranous nephropathy
PDF ~ 283 KB
